Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-06-06

Clinical Trial Update: Epigenetic Regulation of Immunity in Alpha-1 Anti-trypsin Deficiency

View source ↗

Summary

A completed clinical trial investigating epigenetic regulation of immunity in Alpha-1 antitrypsin deficiency.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Jewish Health | Conditions: Alpha 1-Antitrypsin Deficiency | Status: COMPLETED